Ichor Life Sciences Competitors and Similar CompaniesClear all

Lexicon Pharmaceuticals's competitors and similar companies include Ionis Pharmaceuticals and Sierra Sciences.

	Lexicon Pharmaceuticals Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.	Ionis Pharmaceuticals Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.	Sierra Sciences Sierra Sciences is a biotech company that aims to extend the human lifespan and healthspan through telomere maintenance.
Founding Date	Founding Date 1995	Founding Date 1989	Founding Date 1999
Type	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma
Locations	Locations The Woodlands, US HQ Jersey, JE Atlanta, US Bernards, US Birmingham, US Boston, US Charlotte, US see more	Locations Carlsbad, US HQ Vancouver, CA Stuttgart, DE Dublin, IE Dublin, IE Lisboa, PT London, GB see more	Locations Reno, US HQ
Employees	Employees 20216% increase	Employees 1,40231% increase	Employees 20
Valuation ($)	Valuation ($) 737.4 m	Valuation ($) 6.3 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $49.8m (FY, 2025)	Revenue (est.) $943.7m (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods $274k (FY, 2025)	Cost of goods $15.9m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit $49.5m (FY, 2025)	Gross profit $927.8m (FY, 2025)	Gross profit N/A
Net income	Net income ($50.3m) (FY, 2025)	Net income ($381.4m) (FY, 2025)	Net income N/A
Operating ⚠
Phase I Trials Products	Phase I Trials Products 1 (FY, 2016)	Phase I Trials Products 1 (FY, 2023)	Phase I Trials Products N/A
Phase III Trials Products	Phase III Trials Products 2 (FY, 2016)	Phase III Trials Products 17 (FY, 2024)	Phase III Trials Products N/A